NOVAVAX INC (NVAX)

US6700024010 - Common Stock

4.88  +0.9 (+22.61%)

Premarket: 4.9798 +0.1 (+2.05%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

NOVAVAX INC

NASDAQ:NVAX (2/22/2024, 7:00:56 PM)

Premarket: 4.9798 +0.1 (+2.05%)

4.88

+0.9 (+22.61%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap579.70M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

NVAX Daily chart

Company Profile

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company is headquartered in Gaithersburg, Maryland and currently employs 1,992 full-time employees. The firm has developed and begun commercialization of its lead product, NVX-CoV2373, which is a COVID-19 vaccine. NVX-CoV2373 has received approval, interim authorization, provisional approval, conditional marketing authorization (CMA), and emergency use authorization (EUA) from multiple regulatory authorities globally for both adult and adolescent populations as a primary series and for both homologous and heterologous booster indications in over 40 countries. The company is also developing an influenza vaccine candidate, quadrivalent nanoparticle influenza vaccine (qNIV); a COVID-19-Influenza Combination (CIC) vaccine candidate; and additional vaccine candidates, including a COVID-19 variant strain-containing monovalent or bivalent formulation. In addition, its other areas of focus include respiratory syncytial virus (RSV) and malaria.

Company Info

NOVAVAX INC

700 Quince Orchard Road

Gaithersburg MARYLAND 20878

P: 12402682000

CEO: Stanley C. Erck

Employees: 1992

Website: https://www.novavax.com/

NVAX News

News Image18 hours ago - Market News VideoNotable Thursday Option Activity: FCFS, SNOW, NVAX
News Image20 hours ago - ChartmillLet's take a look at the stocks that are in motion in today's session.

Let's take a look at the stocks that are in motion in today's session.

News Image21 hours ago - Seeking AlphaNovavax stock jumps as COVID vaccine row ends (NASDAQ:NVAX)

Novavax (NVAX) stock soars as the company settles a dispute with Gavi over COVID vaccine deliveries, agreeing to pay at least $475M by 2028. Read more here.

News Imagea day ago - InvestorPlaceMorgan Stanley Is Pounding the Table on DoorDash (DASH) Stock

DoorDash stock is rising higher on Thursday after Morgan Stanley upgraded DASH shares and increased their price target for them.

News Imagea day ago - InvestorPlaceMorgan Stanley Issues a Warning on Rivian (RIVN) Stock

Rivian stock is falling hard on Friday as RIVN investors react to a warning from Morgan Stanley and a weak EV production guidance for 2024.

News Imagea day ago - ChartmillTraders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.

Thursday's session: gap up and gap down stocks

NVAX Twits

Here you can normally see the latest stock twits on NVAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example